Institutions Holding Call Options on Day One Biopharmaceuticals, Inc. (DAWN)
This table provides information about the call option holders of Day One Biopharmaceuticals, Inc. (DAWN). We have compiled data on the institutions that hold call options on the stock, with a total of 143,700 call options outstanding, which have been reported (via 13F filing form) to have a value of $1.79 Million at the end of the reported quarter. These call option holders have the right, but not the obligation, to buy AAPL shares at a specified price within a certain time frame.
| Holding | Report Date | calls Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Citigroup Inc
|
Nov 12, 2024 Q3 2024 |
59,900
calls
|
$766,121
0.0% of portfolio
|
N/A
|
|
|
Barclays PLC
London, X0 |
Nov 19, 2024 Q3 2024 |
30,000
calls
|
$383,700
0.0% of portfolio
|
N/A
|
|
|
Caption Management, LLC
Oklahoma City, OK |
Nov 14, 2024 Q3 2024 |
25,000
calls
|
$319,750
0.01% of portfolio
|
N/A
|
|
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
Nov 14, 2024 Q3 2024 |
19,200
calls
|
$245,567
0.0% of portfolio
|
N/A
|
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Nov 14, 2024 Q3 2024 |
9,600
calls
|
$122,783
0.0% of portfolio
|
N/A
|